Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382502655> ?p ?o ?g. }
- W4382502655 endingPage "328" @default.
- W4382502655 startingPage "323" @default.
- W4382502655 abstract "Programmed death ligand-1 (PD-L1, CD274 and B7-H1) has been described as a ligand for immune inhibitory receptor programmed death protein 1 (PD-1). With binding to PD-1 on activated T cells, PD-L1 can prevent T cell responses via motivating apoptosis. Consequently, it causes cancers immune evasion and helps the tumor growth; hence, PD-L1 is regarded as a therapeutic target for malignant cancers. The anti-PD-L1 monoclonal antibody targeting PD-1/PD-L1 immune checkpoint has attained remarkable outcomes in clinical application and has turned to one of the most prevalent anti-cancer drugs. The present study aimed to develop polyclonal heavy chain antibodies targeting PD-L1via Camelus dromedarius immunization. The extra-cellular domain of human PD-L1 (hPD-L1) protein was cloned, expressed, and purified. Afterwards, this recombinant protein was utilized as an antigen for camel immunization to acquire polyclonal camelid sera versus this protein. Our outcomes showed that hPD-L1 protein was effectively expressed in the prokaryotic system. The antibody-based techniques, such as enzyme-linked immunosorbent assay, western blotting, and flow cytometry displayed that the hPD-L1 protein was detected by generated polyclonal antibody. Due to the advantages of multi-epitope-binding ability, our study exhibited that camelid antibody is effective to be applied significantly for detection of PD-L1 protein in essential antibody-based studies." @default.
- W4382502655 created "2023-06-30" @default.
- W4382502655 creator A5019701518 @default.
- W4382502655 creator A5033868588 @default.
- W4382502655 creator A5041240551 @default.
- W4382502655 creator A5043606820 @default.
- W4382502655 creator A5049123919 @default.
- W4382502655 creator A5050947504 @default.
- W4382502655 creator A5071744624 @default.
- W4382502655 creator A5071946331 @default.
- W4382502655 creator A5075047741 @default.
- W4382502655 creator A5076080250 @default.
- W4382502655 creator A5080421221 @default.
- W4382502655 creator A5085162946 @default.
- W4382502655 date "2023-01-01" @default.
- W4382502655 modified "2023-09-23" @default.
- W4382502655 title "Development of polyclonal heavy chain antibodies targeting programmed death ligand-1." @default.
- W4382502655 cites W1881020575 @default.
- W4382502655 cites W1893566975 @default.
- W4382502655 cites W1992360391 @default.
- W4382502655 cites W2030612376 @default.
- W4382502655 cites W2066671159 @default.
- W4382502655 cites W2070469252 @default.
- W4382502655 cites W2108855090 @default.
- W4382502655 cites W2299034615 @default.
- W4382502655 cites W2336130220 @default.
- W4382502655 cites W2560367415 @default.
- W4382502655 cites W2595182131 @default.
- W4382502655 cites W2621536613 @default.
- W4382502655 cites W2747929863 @default.
- W4382502655 cites W2770881248 @default.
- W4382502655 cites W2833678834 @default.
- W4382502655 cites W2886538901 @default.
- W4382502655 cites W2892279874 @default.
- W4382502655 cites W2899873427 @default.
- W4382502655 cites W2945219971 @default.
- W4382502655 cites W3015178699 @default.
- W4382502655 cites W3031825285 @default.
- W4382502655 cites W3048515223 @default.
- W4382502655 cites W3093533116 @default.
- W4382502655 cites W3138556548 @default.
- W4382502655 cites W3165408278 @default.
- W4382502655 cites W3176539066 @default.
- W4382502655 cites W4210666585 @default.
- W4382502655 cites W4249816251 @default.
- W4382502655 doi "https://doi.org/10.30466/vrf.2022.553274.3461" @default.
- W4382502655 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37383651" @default.
- W4382502655 hasPublicationYear "2023" @default.
- W4382502655 type Work @default.
- W4382502655 citedByCount "0" @default.
- W4382502655 crossrefType "journal-article" @default.
- W4382502655 hasAuthorship W4382502655A5019701518 @default.
- W4382502655 hasAuthorship W4382502655A5033868588 @default.
- W4382502655 hasAuthorship W4382502655A5041240551 @default.
- W4382502655 hasAuthorship W4382502655A5043606820 @default.
- W4382502655 hasAuthorship W4382502655A5049123919 @default.
- W4382502655 hasAuthorship W4382502655A5050947504 @default.
- W4382502655 hasAuthorship W4382502655A5071744624 @default.
- W4382502655 hasAuthorship W4382502655A5071946331 @default.
- W4382502655 hasAuthorship W4382502655A5075047741 @default.
- W4382502655 hasAuthorship W4382502655A5076080250 @default.
- W4382502655 hasAuthorship W4382502655A5080421221 @default.
- W4382502655 hasAuthorship W4382502655A5085162946 @default.
- W4382502655 hasConcept C104317684 @default.
- W4382502655 hasConcept C147483822 @default.
- W4382502655 hasConcept C153911025 @default.
- W4382502655 hasConcept C159654299 @default.
- W4382502655 hasConcept C185592680 @default.
- W4382502655 hasConcept C195616568 @default.
- W4382502655 hasConcept C203014093 @default.
- W4382502655 hasConcept C2776415932 @default.
- W4382502655 hasConcept C2777701055 @default.
- W4382502655 hasConcept C2781053074 @default.
- W4382502655 hasConcept C502942594 @default.
- W4382502655 hasConcept C542903549 @default.
- W4382502655 hasConcept C553184892 @default.
- W4382502655 hasConcept C55493867 @default.
- W4382502655 hasConcept C86803240 @default.
- W4382502655 hasConcept C8891405 @default.
- W4382502655 hasConcept C956191 @default.
- W4382502655 hasConceptScore W4382502655C104317684 @default.
- W4382502655 hasConceptScore W4382502655C147483822 @default.
- W4382502655 hasConceptScore W4382502655C153911025 @default.
- W4382502655 hasConceptScore W4382502655C159654299 @default.
- W4382502655 hasConceptScore W4382502655C185592680 @default.
- W4382502655 hasConceptScore W4382502655C195616568 @default.
- W4382502655 hasConceptScore W4382502655C203014093 @default.
- W4382502655 hasConceptScore W4382502655C2776415932 @default.
- W4382502655 hasConceptScore W4382502655C2777701055 @default.
- W4382502655 hasConceptScore W4382502655C2781053074 @default.
- W4382502655 hasConceptScore W4382502655C502942594 @default.
- W4382502655 hasConceptScore W4382502655C542903549 @default.
- W4382502655 hasConceptScore W4382502655C553184892 @default.
- W4382502655 hasConceptScore W4382502655C55493867 @default.
- W4382502655 hasConceptScore W4382502655C86803240 @default.
- W4382502655 hasConceptScore W4382502655C8891405 @default.
- W4382502655 hasConceptScore W4382502655C956191 @default.
- W4382502655 hasIssue "6" @default.